Mitochondrial impairment and oxidative stress in leukocytes after testosterone administration to female-to-male transsexuals

Journal of Sexual Medicine

Volumn 11, Issue 2, 2014, Pages 454-461

  Victor, Víctor M ^a,b,c   Rocha, Milagros ^a,b,c   Bañuls, Celia ^a,b   Rovira Llopis, Susana ^a   Gómez, Marcelino ^a   Hernández Mijares, Antonio ^a,b,c  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Gender Dysphoria; Hormone Therapy in Female to Male Transsexuals; Leukocytes; Mitochondria; Oxidative Stress; Testosterone; Transsexuals

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE UNDECANOATE; DRUG DERIVATIVE; OXYGEN; TESTOSTERONE;

ADULT; ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; FEMALE TO MALE TRANSGENDER; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MEMBRANE POTENTIAL; METABOLIC PARAMETERS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENDER DYSPHORIA; HORMONE THERAPY IN FEMALE-TO-MALE TRANSSEXUALS; MALE; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; SEX REASSIGNMENT; TRANSSEXUALISM; TRANSSEXUALITY; YOUNG ADULT;

GENDER DYSPHORIA; HORMONE THERAPY IN FEMALE-TO-MALE TRANSSEXUALS; LEUKOCYTES; MITOCHONDRIA; OXIDATIVE STRESS; TESTOSTERONE; TRANSSEXUALS;

ADULT; FEMALE; GLUTATHIONE; HUMANS; LEUKOCYTES; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; SEX HORMONE-BINDING GLOBULIN; SEX REASSIGNMENT PROCEDURES; TESTOSTERONE; TRANSSEXUALISM; YOUNG ADULT;

EID: 84901724453     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12376     Document Type: Article

References (44)

1. Gorin-Lazard A, Baumstarck K, Boyer L, Maquigneau A, Gebleux S, Penochet JC, Pringuey D, Albarel F, Morange I, Loundou A, Berbis J, Auquier P, Lançon C, Bonierbale M. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med 2012;9:531-541.
2. Hamburger C. Endocrine treatment of male and female transsexualism. In: Green R, Money J, eds. Transsexualism and sex reassignement. Baltimore, MD: John Hopkins Press; 1969:291-307.
3. Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 2003;88:3467-3473.
4. Gooren LJ, Giltay EJ. Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females. J Sex Med 2008;5:765-776.
5. Asscheman H, Gooren L, Eklund P. Mortality and morbidity in transsexual patients with cross-gender hormones treatment. Metabolism 1989;38:869-873.
6. Futterweit W. Endocrine management of transxesual: Hormonal profiles of serum prolactin, testosterone, and estradiol. N Y State J Med 1980;80:1260-1264.
7. Dizon DS, Tejada-Berges T, Koelliker S, Steinhoff M, Granai CO. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecol Obstet Invest 2006;62:226-228.
8. Goodarzi MO, Ericson S, Port SC, Jennrich RI. Korenmman SG. Beta cell function: A key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:310-315.
9. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes by streptotozin. Inhibition by estrogens and potentiation by androgens. Diabetes 1982;31:724-729.
10. Ripple MO, Hagopian K, Oberley TD, Schatten H, Weindruch R. Androgen-induced oxidative stress in human LNCap prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1999;1:71-81.
11. Pansarasa O, D'Antona G, Gualea MR, Marzani B, Pellegrino MA, Marzatico F. Oxidative stress: Effects of mild endurance training and testosterone treatment on rat gastrocnemius muscle. Eur J Appl Physiol 2002;87:550-555.
12. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:336-340.
13. Diamanti-Kandarakis E, Christakou C, Kandarakis H. Polycystic ovarian syndrome: The commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinol 2007;32:35-47.
14. Ojeda-Ojeda M, Murri M, Insenser M, Escobar-Morreale HF. Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). Curr Pharm Des 2013;19:5775-5791.
15. Victor VM, Rocha M, Bañuls C, Sanchez-Serrano M, Sola E, Gomez M, Hernandez-Mijares A. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 2009;94:3505-3512.
16. Gonzalez F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor alpha release in obese women with polycystic ovary syndrome. J Endocrinol 2006;188:521-529.
17. Victor VM, Rocha M, Bañuls C, Alvarez A, de Pablo C, Sanchez-Serrano M, Gomez M, Hernández-Mijares A. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 2011;96:3115-3122.
18. Christakou C, Diamanti-Kandarakis E. Structural, biochemical and non-traditional cardiovascular risk markers in PCOS. Curr Pharm Des 2013;19:5764-5774.
19. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, Neufer PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573-581.
20. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009;417:1-13.
21. James AM, Collins Y, Logan A, Murphy MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 2012;23:429-434.
22. Rovira-Llopis S, Rocha M, Falcon R, de Pablo C, Alvarez A, Jover A, Hernandez-Mijares A, Victor VM. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes? Antioxid Redox Signal 2013;19:1452-1458.
23. Hernandez-Mijares A, Rocha M, Rovira-Llopis S, Bañuls C, Bellod L, de Pablo C, Alvarez A, Roldan-Torres I, Sola-Izquierdo E, Victor VM. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care 2013;36:1695-1702.
24. Esplugues JV, Rocha M, Nuñez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, D'Ocon P, Victor VM. Complex I dysfunction and tolerance to nitroglycerin: An approach based on mitochondrial-targeted antioxidants. Circ Res 2006;99:1067-1075.
25. Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, Gooren LJ. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 2003;58:562-571.
26. Cupisti S, Giltay EJ, Gooren LJ, Kronawitter D, Oppelt PG, Beckman MW, Dittrich R, Mueller A. The impact of testosterone administration to female to male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome. Fertil Steril 2010;94:2647-2653.
27. Pagotto U, Gambineri A, Pelusi C, Genghini S, Cacciari M, Otto B, Castañeda T, Tschöp M, Pasquali R. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 2003;88:4139-4143.
28. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013;10:245-284.
29. Corona G, Gacci M, Baldi E, Mancina R, Forti G, Maggi M. Androgen deprivation therapy in prostate cancer: Focusing on sexual side effects. J Sex Med 2012;9:887-902.
30. Gonzalez F, Sreekumaran N, Daniels JK, Basal E, Schimke JM, Blair HE. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab 2012;97:2836-2843.
31. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K. Reduced expression of nuclear-encoded genes involved in mitochondrial metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007;56:2349-2355.
32. Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Hum Reprod Update 2013;19:268-288.
33. Psarra AM, Sekeris CE. Steroid and thyroid hormone receptors in mitochondria. IUBMB Life 2008;60:210-223.
34. Goldenthal MJ, Marin-Garcia J. Mitochondrial signalling pathways: A receiver/integrator organelle. Mol Cell Biochem 2004;262:1-16.
35. Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol 2007;17:292-301.
36. Duckles SP, Krause DN, Stirone C, Procaccio V. Estrogen and mitochondria: A new paradigm for vascular protection? Mol Interv 2006;6:26-35.
37. Stirone C, Duckles SP, Krause DN, Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005;68:959-965.
38. De la Fuente M, Victor VM. Antioxidants as modulators of immune function. Immunol Cell Biol 2000;78:49-54.
39. Sela S, Mazor R, Amsalam M, Yagil C, Yagil Y, Kristal B. Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat. Hypertension 2004;44:764-769.
40. Rocha M, Apostolova N, Herance JR, Rovira-Llopis S, Hernandez-Mijares A, Victor VM. Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes. Med Res Rev 2013. doi: 10.1002/med.21285.
41. Victor VM, Rocha M, De la Fuente M. Immune cells: Free radicals and antioxidants in sepsis. Int Immunopharmacol 2004;4:327-347.
42. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: Antioxidant therapy. Curr Pharm Des 2005;11:3141-3158.
43. Yang YT, Whiteman M, Gieseg SP. Intracellular glutathione protects human monocyte-derived macrophages from hypochlorite damage. Life Sci 2012;90:682-688.
44. Monsalve M, Borniquel S, Valle I, Lamas S. Mitochondrial dysfunction in human pathologies. Front Biosci 2007;12:1131-1153.